3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
4
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Gastrointestinal
1
Endocrine
1
Conditions
Diarrhea
3
Prostatic Neoplasms
2
Neoplasms
2
Breast Neoplasms
2
Vipoma
1
Somatostatinoma
1
Serotonin Syndrome
1
Recurrence
1
Rectal Neoplasms
1
Pheochromocytoma
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Lymphocele
1
Intestinal Obstruction
1
Insulinoma
1
Head and Neck Neoplasms
1
Glucagonoma
1
Gastro-enteropancreatic neuroendocrine tumor
1
Gastrinoma
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Medullary
1
Carcinoma, Islet Cell
1
Adenoma, Islet Cell
1
Adenoma
1
Acromegaly
1
Interventions
lanreotide
2
Octreotide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Acromegaly
×
Octreotide
×
Clear all
NCT05364944
2025-11-17
OXTEND-01
Debiopharm International SA
Phase 1
Terminated
19 enrolled